Pharmaron has signed a deal to obtain a majority stake in Shin Nippon Biomedical Laboratories Clinical Pharmacology Center in Baltimore, MD., the fourth acquisition it sealed in about a year.
China’s Pharmaron has picked up an R&D facility in the U.K. from Merck & Co. for an undisclosed lease amount. The move gives Pharmaron a growing foothold in Europe.
